Zum Hauptinhalt springen

VPAC receptor signaling modulates grouping behavior and social responses to contextual novelty in a gregarious finch: a role for a putative prefrontal cortex homologue.

Kingsbury, MA ; Miller, KM ; et al.
In: Hormones and behavior, Jg. 64 (2013-08-01), Heft 3, S. 511
Online academicJournal

Titel:
VPAC receptor signaling modulates grouping behavior and social responses to contextual novelty in a gregarious finch: a role for a putative prefrontal cortex homologue.
Autor/in / Beteiligte Person: Kingsbury, MA ; Miller, KM ; Goodson, JL
Link:
Zeitschrift: Hormones and behavior, Jg. 64 (2013-08-01), Heft 3, S. 511
Veröffentlichung: New York, London, Academic Press., 2013
Medientyp: academicJournal
ISSN: 1095-6867 (electronic)
DOI: 10.1016/j.yhbeh.2013.07.004
Schlagwort:
  • Animals
  • Anxiety physiopathology
  • Behavior, Animal drug effects
  • Environment
  • Exploratory Behavior drug effects
  • Female
  • Male
  • Prefrontal Cortex physiology
  • Receptors, Vasoactive Intestinal Peptide antagonists & inhibitors
  • Recombinant Fusion Proteins pharmacology
  • Signal Transduction drug effects
  • Signal Transduction physiology
  • Vasoactive Intestinal Peptide analogs & derivatives
  • Vasoactive Intestinal Peptide antagonists & inhibitors
  • Behavior, Animal physiology
  • Exploratory Behavior physiology
  • Finches physiology
  • Neurotensin pharmacology
  • Prefrontal Cortex drug effects
  • Receptors, Vasoactive Intestinal Peptide physiology
  • Social Behavior
  • Vasoactive Intestinal Peptide pharmacology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article
  • Language: English
  • [Horm Behav] 2013 Aug; Vol. 64 (3), pp. 511-8. <i>Date of Electronic Publication: </i>2013 Jul 27.
  • MeSH Terms: Social Behavior* ; Behavior, Animal / *physiology ; Exploratory Behavior / *physiology ; Finches / *physiology ; Neurotensin / *pharmacology ; Prefrontal Cortex / *drug effects ; Receptors, Vasoactive Intestinal Peptide / *physiology ; Vasoactive Intestinal Peptide / *pharmacology ; Animals ; Anxiety / physiopathology ; Behavior, Animal / drug effects ; Environment ; Exploratory Behavior / drug effects ; Female ; Male ; Prefrontal Cortex / physiology ; Receptors, Vasoactive Intestinal Peptide / antagonists & inhibitors ; Recombinant Fusion Proteins / pharmacology ; Signal Transduction / drug effects ; Signal Transduction / physiology ; Vasoactive Intestinal Peptide / analogs & derivatives ; Vasoactive Intestinal Peptide / antagonists & inhibitors
  • References: Ann N Y Acad Sci. 1999 Jun 29;877:242-57. (PMID: 10415653) ; Brain Behav Evol. 1997;49(2):78-98. (PMID: 9031732) ; Brain Behav Evol. 1995;45(3):153-77. (PMID: 7796094) ; Endocrinology. 2008 Jun;149(6):3130-6. (PMID: 18326000) ; J Comp Neurol. 2004 Aug 30;476(4):388-413. (PMID: 15282712) ; Brain Res. 2011 Nov 8;1422:20-31. (PMID: 21974861) ; Brain Res. 1980 Mar 17;186(1):165-83. (PMID: 6986955) ; Br J Pharmacol. 2012 May;166(1):4-17. (PMID: 22289055) ; Gen Comp Endocrinol. 1996 Oct;104(1):76-83. (PMID: 8921358) ; Neuroscience. 1982 Jan;7(1):99-131. (PMID: 6176906) ; Gen Comp Endocrinol. 1999 Jan;113(1):146-54. (PMID: 9882553) ; Horm Behav. 2005 Aug;48(2):196-206. (PMID: 15878570) ; Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):17013-7. (PMID: 17071744) ; Horm Behav. 2012 Mar;61(3):239-50. (PMID: 22269661) ; J Comp Neurol. 2004 Jul 26;475(3):426-61. (PMID: 15221956) ; Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):78-84. (PMID: 11483244) ; Pharmacol Rev. 2000 Jun;52(2):269-324. (PMID: 10835102) ; Horm Behav. 1990 Jun;24(2):215-31. (PMID: 2194925) ; Psychoneuroendocrinology. 2009 Jul;34(6):833-43. (PMID: 19181454) ; J Comp Neurol. 1991 Mar 15;305(3):393-411. (PMID: 1645376) ; Gen Comp Endocrinol. 1998 Aug;111(2):233-44. (PMID: 9679095) ; J Mol Neurosci. 1989;1(1):55-61. (PMID: 2642065) ; J Neurosci. 2002 Nov 15;22(22):10046-52. (PMID: 12427862) ; Horm Behav. 1998 Aug;34(1):67-77. (PMID: 9735230) ; Gen Comp Endocrinol. 1999 Mar;113(3):323-30. (PMID: 10068494) ; J Mol Neurosci. 2007;31(3):183-200. (PMID: 17726225) ; J Comp Neurol. 1996 Dec 02;376(1):1-27. (PMID: 8946281) ; J Neurosci. 2004 Oct 6;24(40):8786-95. (PMID: 15470144) ; Physiol Behav. 2010 Aug 4;101(1):141-52. (PMID: 20451539) ; Horm Behav. 2007 Nov;52(4):445-53. (PMID: 17678929) ; Horm Behav. 2008 Jan;53(1):287-94. (PMID: 18036596) ; Neurosci Biobehav Rev. 2005 Feb;29(1):137-50. (PMID: 15652261) ; Am Nat. 2007 Dec;170(6):864-75. (PMID: 18171169) ; Cell Tissue Res. 1994 Jan;275(1):91-107. (PMID: 8118850) ; J Comp Neurol. 1991 Dec 15;314(3):478-92. (PMID: 1726107) ; Neuropsychopharmacology. 2009 Oct;34(11):2459-68. (PMID: 19553916) ; Acta Histochem. 2013 Apr;115(3):209-18. (PMID: 22795268) ; Eur J Neurosci. 2008 Sep;28(5):883-92. (PMID: 18717734) ; Science. 2009 Aug 14;325(5942):862-6. (PMID: 19679811) ; PLoS One. 2010 Jul 14;5(7):e11597. (PMID: 20644737) ; J Endocrinol. 1981 Sep;90(3):437-43. (PMID: 7276801) ; Neurosci Lett. 2003 Feb 27;338(2):155-8. (PMID: 12566176) ; Gen Comp Endocrinol. 1988 Nov;72(2):226-36. (PMID: 3197943) ; Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13847-52. (PMID: 22872869) ; Behav Neurosci. 2001 Aug;115(4):910-9. (PMID: 11508730) ; Horm Behav. 2012 Mar;61(3):454-61. (PMID: 22300676) ; Horm Behav. 2009 Jan;55(1):197-202. (PMID: 19013174) ; Int J Dev Neurosci. 2008 Aug;26(5):423-34. (PMID: 18423945) ; Pharmacol Rev. 2009 Sep;61(3):283-357. (PMID: 19805477) ; J Neuroendocrinol. 1999 Jan;11(1):19-25. (PMID: 9918225) ; Behav Brain Res. 1992 Nov 15;51(2):149-55. (PMID: 1466781) ; Exp Neurol. 2007 Jul;206(1):101-13. (PMID: 17521630) ; Science. 2011 Jul 15;333(6040):353-7. (PMID: 21764750) ; Behav Neurosci. 2009 Oct;123(5):979-91. (PMID: 19824764) ; Anim Cogn. 2010 Sep;13(5):701-10. (PMID: 20300791) ; Gen Comp Endocrinol. 2008 Jun;157(2):91-8. (PMID: 18555065) ; Proc Natl Acad Sci U S A. 2012 Jun 26;109 Suppl 1:10685-92. (PMID: 22723363) ; J Mol Neurosci. 2003 Apr;20(2):163-72. (PMID: 12794310) ; J Comp Neurol. 2003 May 5;459(3):301-26. (PMID: 12655512) ; J Comp Neurol. 1987 Sep 8;263(2):290-307. (PMID: 3312309) ; Exp Neurol. 2008 May;211(1):67-84. (PMID: 18316078) ; Gen Comp Endocrinol. 1986 Jun;62(3):470-8. (PMID: 3770438) ; J Neuroendocrinol. 2007 Aug;19(8):605-13. (PMID: 17620102) ; J Exp Zool. 1984 Dec;232(3):521-9. (PMID: 6240524) ; J Comp Neurol. 1997 Apr 28;381(1):101-18. (PMID: 9087422) ; Horm Behav. 2001 Sep;40(2):133-8. (PMID: 11534973) ; J Comp Neurol. 2011 May 1;519(7):1371-94. (PMID: 21452202) ; Horm Behav. 2006 Aug;50(2):223-36. (PMID: 16643915) ; Horm Behav. 1983 Mar;17(1):54-65. (PMID: 6862393) ; Endocrinology. 1992 Apr;130(4):1796-801. (PMID: 1547709) ; Regul Pept. 1995 Nov 10;59(3):321-33. (PMID: 8577937) ; Prog Neurobiol. 1998 Mar;54(4):417-58. (PMID: 9522395) ; Horm Behav. 2011 Jun;60(1):12-21. (PMID: 21295577) ; Horm Behav. 2005 Jun;48(1):11-22. (PMID: 15885690) ; Brain Behav Evol. 2001 May;57(5):252-70. (PMID: 11641562) ; J Comp Neurol. 1978 Jul 1;180(1):59-71. (PMID: 649789) ; Regul Pept. 1994 May 26;51(3):221-7. (PMID: 7938706) ; Behav Brain Res. 1999 Jun;101(2):129-52. (PMID: 10372570) ; Front Behav Neurosci. 2009 Sep 15;3:25. (PMID: 19826497) ; Neuroendocrinology. 1991;53 Suppl 1:45-51. (PMID: 1901391) ; Behav Neurosci. 1989 Oct;103(5):1009-16. (PMID: 2803548)
  • Grant Information: R01 MH092331 United States MH NIMH NIH HHS
  • Contributed Indexing: Keywords: Affiliation; Anxiety-like behavior; Gregariousness; Social approach; Vasoactive intestinal polypeptide; Zebra finches
  • Substance Nomenclature: 0 (Receptors, Vasoactive Intestinal Peptide) ; 0 (Recombinant Fusion Proteins) ; 125093-93-8 ((VIP-neurotensin) hybrid antagonist) ; 37221-79-7 (Vasoactive Intestinal Peptide) ; 39379-15-2 (Neurotensin)
  • Entry Date(s): Date Created: 20130801 Date Completed: 20140701 Latest Revision: 20211021
  • Update Code: 20231215
  • PubMed Central ID: PMC3864561

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -